Medical Market Report

Global Non-opioid Pain Patch Market By Type (Lidocaine Patches, Diclofenac Patches, Methyl Salicylate Patches, Capsaicin Patches, Ketoprofen Patches, and Others), By Application (Hospital Pharmacies, Online Pharmacies, and Independent Pharmacies & Drug Stores), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029

  • 136981
  • 18-Dec
  • PDF/PPT/Word
  • ★ ★ ★ ★ ★
    ★ ★ ★ ★ ★
  • Report Details

    The report on Non-opioid Pain Patch Market offers in-depth analysis of market trends, drivers, restraints, opportunities etc. Along with qualitative information, this report includes the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. The global non-opioid pain patch market is segmented on the basis of Type, Application, and geography.

    The global Non-opioid Pain Patch market is estimated to be US$ XX.X Mn in 2019 and is projected to increase significantly at a CAGR of x.x% from 2020 to 2028.

    Non-opioid Pain Patch Market Scope:

    By type, the market is segmented into Lidocaine Patches, Diclofenac Patches, Methyl Salicylate Patches, Capsaicin Patches, Ketoprofen Patches, and Others. By Application, the market is divided into Hospital Pharmacies, Online Pharmacies, and Independent Pharmacies & Drug Stores.
    Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include GlaxoSmithKline plc, Pfizer, Inc., Teikoku Seiyaku Co., Ltd., Mylan N.V., Hisamitsu Pharmaceutical Co.,Inc, Acorda Therapeutics, Inc, Endo International plc, Allergan, Teh Seng Pharmaceutical Mfg, and IBSA Institut Biochimque SA.

    Key Market Segments

    Type

    Lidocaine Patches

    Diclofenac Patches

    Methyl Salicylate Patches

    Capsaicin Patches

    Ketoprofen Patches

    Others

    Application

    Hospital Pharmacies

    Online Pharmacies

    Independent Pharmacies & Drug Stores

    Key Market Players included in the report:

    GlaxoSmithKline plc

    Pfizer, Inc.

    Teikoku Seiyaku Co., Ltd.

    Mylan N.V.

    Hisamitsu Pharmaceutical Co.,Inc

    Acorda Therapeutics, Inc

    Endo International plc

    Allergan

    Teh Seng Pharmaceutical Mfg

    IBSA Institut Biochimque SA

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis industry research (global industry trends) and Non-opioid Pain Patch Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Non-opioid Pain Patch Market; high-growth regions; and market drivers, restraints, and also market chances.
    The analysis covers Non-opioid Pain Patch Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Non-opioid Pain Patch Market across sections such as also Application and representatives.
    Additionally, the analysis also has a comprehensive review of the crucial players on the Non-opioid Pain Patch Market together side their company profiles, SWOT analysis, latest advancements, and business plans.

    The analysis objectives of the report are:

    To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
    To know the Non-opioid Pain Patch Market by pinpointing its many subsegments.
    To profile the important players and analyze their growth plans.
    To endeavor the amount and value of Non-opioid Pain Patch sub-markets, depending on key regions (various vital states).
    To analyze Non-opioid Pain Patch Market concerning growth trends, prospects, and also their participation in the entire sector.
    To examine and study the Non-opioid Pain Patch Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2014 to 2019, and also prediction to 2028.
    Primary worldwide Non-opioid Pain Patch Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.

  • Table Of Content 
    1. Non-opioid Pain Patch Market Introduction
    

    1.1. Definition
    
1.2. Taxonomy
    
1.3. Research Scope2. Executive Summary
    

      2.1. Key Findings by Major Segments
    
  2.2. Top strategies by Major Players3. Global Non-opioid Pain Patch Market Overview
    

    3.1. Non-opioid Pain Patch Market Dynamics
    

        3.1.1. Drivers
    
    3.1.2. Opportunities
    
    3.1.3. Restraints
    
    3.1.4. Challenges  3.2. PESTLE Analysis
    
  3.3. Opportunity Map Analysis
    
  3.4. PORTER’S Five Forces Analysis
    
  3.5. Market Competition Scenario Analysis
    
  3.6. Product Life Cycle Analysis
    
  3.7. Opportunity Orbits
    
  3.8. Production Analysis by Region/Company
    
  3.9. Industry chain Analysis
    
  3.10. Marketing Strategy4. Global Non-opioid Pain Patch Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
    

      4.1. Global Non-opioid Pain Patch Market Analysis by Type: Introduction
    
  4.2. Market Size and Forecast by Region
    
  4.3. Lidocaine Patches
    

      4.4. Diclofenac Patches
    

      4.5. Methyl Salicylate Patches
    

      4.6. Capsaicin Patches
    

      4.7. Ketoprofen Patches
    

      4.8. Others5. Global Non-opioid Pain Patch Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
    

      5.1. Global Non-opioid Pain Patch Market Analysis by Application: Introduction
    
  5.2. Market Size and Forecast by Region
    
  5.3. Hospital Pharmacies
    

      5.4. Online Pharmacies
    

      5.5. Independent Pharmacies & Drug Stores6. Global Non-opioid Pain Patch Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
    

      6.1. North America
    

        6.1.1. North America Non-opioid Pain Patch Market: Regional Trend Analysis
    

         6.1.1.1. US
    
     6.1.1.2. Canada
    
     6.1.1.3. Mexico
    

      6.2.1. Europe
    

        6.2.1. Europe Non-opioid Pain Patch Market: Regional Trend Analysis
    

         6.2.1.1. Germany
    
     6.2.1.2. France
    
     6.2.1.3. UK
    
     6.2.1.4. Russia
    
     6.2.1.5. Italy
    
     6.2.1.6. Spain
    
     6.2.1.7. Rest of Europe
    

      6.3. Asia-Pacific
    

        6.3.1. Asia-Pacific Non-opioid Pain Patch Market: Regional Trend Analysis
    

         6.3.1.1. China
    
     6.3.1.2. Japan
    
     6.3.1.3. Korea
    
     6.3.1.4. India
    
     6.3.1.5. Rest of Asia-Pacific
    

      6.4. Latin America
    

        6.4.1. Latin America Non-opioid Pain Patch Market: Regional Trend Analysis
    

         6.4.1.1. Brazil
    
     6.4.1.2. Argentina
    
     6.4.1.3. Rest of Latin America
    

      6.5. Middle East and Africa
    

        6.5.1. Middle East and Africa Non-opioid Pain Patch Market: Regional Trend Analysis
    

         6.5.1.1. GCC
    
     6.5.1.2. South Africa
    
     6.5.1.3. Israel
    
     6.5.1.4. Rest of MEA
    
7. Global Non-opioid Pain Patch Market Competitive Landscape, Market Share Analysis, and Company Profiles
    

      7.1. Market Share Analysis
    
  7.2. Company Profiles
    
  7.3. GlaxoSmithKline plc
    

        7.3.1. Company Overview
    
    7.3.2. Financial Highlights
    
    7.3.3. Product Portfolio
    
    7.3.4. SWOT Analysis
    
    7.3.5. Key Strategies and Developments  7.4. Pfizer, Inc.
    

        7.4.1. Company Overview
    
    7.4.2. Financial Highlights
    
    7.4.3. Product Portfolio
    
    7.4.4. SWOT Analysis
    
    7.4.5. Key Strategies and Developments  7.5. Teikoku Seiyaku Co., Ltd.
    

        7.5.1. Company Overview
    
    7.5.2. Financial Highlights
    
    7.5.3. Product Portfolio
    
    7.5.4. SWOT Analysis
    
    7.5.5. Key Strategies and Developments  7.6. Mylan N.V.
    

        7.6.1. Company Overview
    
    7.6.2. Financial Highlights
    
    7.6.3. Product Portfolio
    
    7.6.4. SWOT Analysis
    
    7.6.5. Key Strategies and Developments  7.7. Hisamitsu Pharmaceutical Co.,Inc
    

        7.7.1. Company Overview
    
    7.7.2. Financial Highlights
    
    7.7.3. Product Portfolio
    
    7.7.4. SWOT Analysis
    
    7.7.5. Key Strategies and Developments  7.8. Acorda Therapeutics, Inc
    

        7.8.1. Company Overview
    
    7.8.2. Financial Highlights
    
    7.8.3. Product Portfolio
    
    7.8.4. SWOT Analysis
    
    7.8.5. Key Strategies and Developments  7.9. Endo International plc
    

        7.9.1. Company Overview
    
    7.9.2. Financial Highlights
    
    7.9.3. Product Portfolio
    
    7.9.4. SWOT Analysis
    
    7.9.5. Key Strategies and Developments  7.10. Allergan
    

        7.10.1. Company Overview
    
    7.10.2. Financial Highlights
    
    7.10.3. Product Portfolio
    
    7.10.4. SWOT Analysis
    
    7.10.5. Key Strategies and Developments  7.11. Teh Seng Pharmaceutical Mfg
    

        7.11.1. Company Overview
    
    7.11.2. Financial Highlights
    
    7.11.3. Product Portfolio
    
    7.11.4. SWOT Analysis
    
    7.11.5. Key Strategies and Developments  7.12. IBSA Institut Biochimque SA
    

        7.12.1. Company Overview
    
    7.12.2. Financial Highlights
    
    7.12.3. Product Portfolio
    
    7.12.4. SWOT Analysis
    
    7.12.5. Key Strategies and Developments
    

    8. Assumptions and Acronyms
    
9. Research Methodology
    
10. Contact
  • Inquiry Before Buying

    Inquiry Form

  • Request Sample

    Request for Sample

Related Reports

Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.